Potential for prostaglandin use in controlling human reproduction

  • K. T. Kirton
  • F. A. Kimball
Part of the Advances in Reproductive Health Care book series (ARHE, volume 4)


It was observed in 1930 that seminal plasma of a number of species contained very large amounts of substance(s) capable of altering uterine motility. These substances were subsequently demonstrated to be prostaglandins (PGs); this began the early and continued association of this group of compounds with reproduction. The activity was found to be associated with a fraction containing lipid–soluble acids, derived from prostanoic acid. Restrictions imposed by obscure sources and small amounts of material available for testing were initially impediments to their study. However, after some time and considerable effort, a cooperative venture by The Upjohn Company and scientists at the Karolinska Institute resulted in the isolation of compound in pure form from sheep vesicular glands. The structures of PGE1 and PGF were subsequently determined (Bergstrom et al., 1968; Bergstrom and Sjovall, 1957). Larger amounts of materials were then prepared which enabled biologists to investigate their properties more extensively in a number of tests.


Corpus Luteum Seminal Plasma Arachidonic Acid Cascade Fertility Regulation Bovine Corpus Luteum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bartol, F. F., Thatcher, W. W., Bazer, F. W., Kimball, F. A., Chenault, J. R., Wilcox, C. J. and Roberts, R. M. (1981). Effects of the estrous cycle and early pregnancy on bovine uterine, luteal and follicular responses. Biol. Reprod., 25, 759–776PubMedCrossRefGoogle Scholar
  2. Bergström, S. and Sjovall, J. (1957). The isolation of Prostaglandins. Acta Chem. Scand., 11, 1086CrossRefGoogle Scholar
  3. Bergström, S., Carlson, L. A. and Weeks, J. R. (1968). The Prostaglandins: a family of biologically active lipids. Pharmacol. Rev., 20, 1–48PubMedGoogle Scholar
  4. Bergström, S., Ryhage, R., Samuelsson, B. and Sjovall, J. (1963). Degradation studies on Prostaglandins. Acta Chem. Scand., 17, 2271–2280CrossRefGoogle Scholar
  5. Bundy, G., Lincoln, F., Nelson, N., Pike, J. and Schneider, W. (1971). Novel Prostaglandin syntheses. Ann. NY Acad. Sci., 180, 76–90PubMedCrossRefGoogle Scholar
  6. Bygdeman, M., Christensen, N. J., Green, K. and Zhery, S. (1981). Self administration of Prostaglandin for termination of early pregnancy. Contraception, 24, 45–52PubMedCrossRefGoogle Scholar
  7. Calder, A. A., Embrey, M. P. and Tait, T. (1977). Ripening of the cervix with extra–amniotic Prostaglandin E2 in viscous gel before induction of labor. Br. J. Obstet. Gynaecol., 84, 264–268PubMedCrossRefGoogle Scholar
  8. Fitz, J. A., Mayan, M. H., Sawyer, H. R. and Niswender, G. D. (1982). Characterization of two steroidogenic cell types in the ovine corpus luteum. Biol. Reprod., 27, 703–711PubMedCrossRefGoogle Scholar
  9. Ganguli, A. C., Gréen, K. and Bygdeman, M. (1977). Preoperative dilatation of the cervix by single vaginal administration of 15–methyl–PGF2aα methyl ester. Prostaglandins, 14, 779–784PubMedCrossRefGoogle Scholar
  10. Goding, J. R. (1974). The demonstration that PGF is the uterine luteolysin in the ewe. J. Reprod. Fertil., 38, 261–271PubMedCrossRefGoogle Scholar
  11. Granström, E. (1983). The Prostaglandins, thromboxanes and leukotrienes. In: The importance of Prostaglandins in obstetrics and gynecology. Acta Obstet. Gynecol. Scand., Suppl. 113, 9–14Google Scholar
  12. Greene, S. I. and Gilling, E. A. (1979). Postconceptional menses induction with a single dose of (15S)–15–methyl Prostaglandin F methyl ester in a silicone vaginal device. Acta Therapeutica, 5, 143–153Google Scholar
  13. Gutknecht, G. D., Cornette, J. C. and Pharriss, B. B. (1969). Antifertility properties of Prostaglandin F. Biol. Reprod., 1, 367–371PubMedCrossRefGoogle Scholar
  14. Hinman, J. (1972). Prostaglandins. Ann. Rev. Biochem., 41, 161–178PubMedCrossRefGoogle Scholar
  15. Kajanoja, P. (1983). Induction of abortion by Prostaglandins in the second trimester of pregnancy. A review. Acta Obstet. Gynecol. Scand., Suppl. 113, 145–152CrossRefGoogle Scholar
  16. Karim, S. M. M. (1975). Advances in Prostaglandin research. In Karim, S. M. M. (ed.). Prostaglandins and Reproduction. (Lancaster: MTP Press)Google Scholar
  17. Kimball, F. A. (1974). Uterine Prostaglandin binding proteins. Prostaglandins, 6, 541CrossRefGoogle Scholar
  18. Kimball, F. A. (1983). Role of PGI2 and other Prostaglandins in pregnancy. In Lewis, P. J., O’Grady, J. and Moncoda, S. (eds.). Prostacyclin and Pregnancy, pp. 1–13. (London: Raven Press)Google Scholar
  19. Kimball, F. A. and Kirton, K. T. (1977). Prostaglandins as antifertility agents. In Goldberg, M. E. (ed.). Pharmacological and Biochemical Properties of Drug Substances, pp. 373–386. (Washington, DC: American Pharmaceutical Association)Google Scholar
  20. Kimball, F. A. and Lauderdale, J. W. (1975). Prostaglandin E1 and F specific binding in bovine corpora lutea: comparison with luteolytic effects. Prostaglandins, 10, 313–331PubMedGoogle Scholar
  21. Kimball, F. A., Bundy, G. L., Robert, A. and Weeks, J. R. (1979). Synthesis and biological properties of 9–deoxo–16, 16–dimethyl–9–methylene-PGE2. Prostaglandins, 17, 657–666PubMedCrossRefGoogle Scholar
  22. Kirton, K. T., Kimball, F. A. and Porteus, S. E. (1976). Reproductive physiology: prostaglandin–associated events. In Paoletti, R. and Samuelsson, B. (eds.). Advances in Prostaglandin and Thromboxane Research, Vol. 2, pp. 621–625. (New York: Raven Press)Google Scholar
  23. Kirton, K. T., Pharriss, B. B. and Forbes, A. D. (1970). Some effects of Prostaglandins E2 and F; on the pregnant rhesus monkey. Biol. Reprod., 3, 163–168PubMedGoogle Scholar
  24. Lange, A. P., Westergaard, J. G., Secher, N. J. and Pedersen, G. T. (1983). Labor induction with Prostaglandins. Acta. Obstet. Gynecol. Scand., Suppl. 113, 177–185CrossRefGoogle Scholar
  25. Mackenzie, I. R. and Embrey, M. P. (1977). Cervical ripening with intravaginal Prostaglandin E2 gel. Br. Med.J., 2, 1381–1384PubMedCrossRefGoogle Scholar
  26. Mackenzie, R. D. and Embrey, M. P. (1978). The influence of pre–induction vaginal Prostaglandin E2 gel upon subsequent labor. Br. J. Obstet. Gynaecol., 84, 657–661Google Scholar
  27. Norström, A., Wilhelmsson, L. and Hamberger, L. (1983). Experimental studies on the influence of Prostaglandins on the connective tissue of the human cervix uteri. Acta Obstet. Gynecol. Scand., Suppl. 113, 167–170CrossRefGoogle Scholar
  28. Pharriss, B. B. (1970). The possible vascular regulation of luteal function. Perspect. Biol. Med., 13, 434–444PubMedGoogle Scholar
  29. Pharriss, B. B. and Kirton, K. T. (1969). Prostaglandin F: a new contraceptive approach. Excerpta Med. Int. Congr., Ser No. 207, 2185Google Scholar
  30. Roseman, T. J., Spilman, C. H., Tuttle, M. E., Lee, E. K. L. and Lonsdale, H. K. (1982). Membrane controlled delivery of Prostaglandins. Contraceptive Deliv. Syst., 3, 460Google Scholar
  31. Samuelsson, B.. Granström, E., Gréen, K. and Hamberg, M. (1971). Metabolism of Prostaglandins. Ann. NY Acad. Sci., 180, 138–163Google Scholar
  32. Sharma, S. D., Hale, R. W. and Steinmiller, V. (1983). Intramuscular administration of 15(S)–15 methyl Prostaglandin F and olaminaria insertion for termination of mid trimester pregnancy. Contraceptive Deliv. Syst., 3, 477Google Scholar
  33. Shepard, J., Pearce, J. M. F. and Sims, C. D. (1979). Induction of labor using Prostaglandin E2 pessaries. Br. Med. J., 2, 108–110CrossRefGoogle Scholar
  34. World Health Organization (1983). Report of task force on the use of Prostaglandins for fertility regulation. Int. J. Gynaecol. Obstet., 21, 159–165CrossRefGoogle Scholar

Copyright information

© MTP Press Limited 1984

Authors and Affiliations

  • K. T. Kirton
  • F. A. Kimball

There are no affiliations available

Personalised recommendations